Clinical Trials Directory

Trials / Unknown

UnknownNCT02698046

Oral Iron Therapy in Chronic Heart Failure Patients

Oral Iron Therapy in Chronic Heart Failure Patients: a Randomized, Placebo-controlled and Double-blind Clinical Trial (Pilot Study) of Efficiency

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is design to evaluate the effectiveness of oral iron therapy in patients with heart failure and identify the central and peripheral mechanisms involved in the improvement of functional capacity after intervention. The investigation includes subjective and objective measures on exercise performance and heart function after intervention, and the tolerability of oral iron treatment.

Detailed description

This is a placebo-controlled, double-blind and randomized clinical trial that will include patients with symptomatic stable chronic heart failure (New York Heart Association Functional Class II or III), with diagnosis of iron deficiency (ferritin \<100 ng / dL or ferritin between 100 - 300 ng / dL and transferrin saturation \<20%) followed in an outpatient clinic. The enrolled patients (n = 36) will be randomly allocated in the ratio 2:1 to treatment with 60 mg of elemental iron orally (n = 24) or placebo administration (n = 12), 3 times daily for 4 months. The primary outcome investigated will be an increase of the transferrin saturation ≥ 10 percentage points between baseline and after the intervention. Secondary outcomes of the study will be the change in iron stores, red blood cell indices, neurohumoral activation, left ventricular systolic function, functional capacity, mechanoreflex activity, and quality life score.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFerrous sulfate200mg of ferrous sulfate three times a day for 4 months
DIETARY_SUPPLEMENTPlacebo starch200mg of placebo starch three times a day for 4 months

Timeline

Start date
2015-08-01
Primary completion
2016-06-01
Completion
2016-10-01
First posted
2016-03-03
Last updated
2016-03-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02698046. Inclusion in this directory is not an endorsement.